Day One Biopharmaceuticals, Inc.
DAWN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$19,726 | -$30,322 | -$35,996 | -$65,714 |
| Dep. & Amort. | $885 | $886 | $819 | $759 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $9,561 | $10,898 | $12,861 | $11,035 |
| Change in WC | $7,547 | -$2,265 | -$32,506 | $26,735 |
| Other Non-Cash | -$4,072 | -$4,003 | -$4,175 | -$2,823 |
| Operating Cash Flow | -$5,805 | -$24,806 | -$58,997 | -$30,008 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$3 | -$317 | $15,681 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$209,565 | -$238,502 | -$189,796 | -$275,221 |
| Inv. Sales/Matur. | $223,025 | $264,795 | $161,000 | $7,000 |
| Other Inv. Act. | $0 | $0 | -$3,500 | -$17,100 |
| Investing Cash Flow | $13,460 | $26,322 | -$32,613 | -$269,640 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $1,851 |
| Stock Repurch. | $0 | $748 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $0 | $748 | $0 | $1,851 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $7,655 | $2,264 | -$91,610 | -$297,797 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $35,622 | $33,358 | $124,968 | $422,765 |
| End Cash | $43,277 | $35,622 | $33,358 | $124,968 |
| Free Cash Flow | -$5,805 | -$21,309 | -$62,814 | -$31,427 |